Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-292371
Filing Date
2022-11-25
Accepted
2022-11-25 08:41:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d392945dsc13g.htm SC 13G 47569
  Complete submission text file 0001193125-22-292371.txt   49105
Mailing Address KOENIGSALLEE 20 DUESSELDORF 2M 40212
Business Address KOENIGSALLEE 20 DUESSELDORF 2M D 40212 49211353266
ROI VERWALTUNGS GMBH (Filed by) CIK: 0001279237 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88651 | Film No.: 221417999
SIC: 2834 Pharmaceutical Preparations